BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 10722669)

  • 1. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.
    Ward JL; Sherali A; Mo ZP; Tse CM
    J Biol Chem; 2000 Mar; 275(12):8375-81. PubMed ID: 10722669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
    SenGupta DJ; Unadkat JD
    Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta.
    Griffiths M; Yao SY; Abidi F; Phillips SE; Cass CE; Young JD; Baldwin SA
    Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):739-43. PubMed ID: 9396714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
    Hammond JR
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.
    Endres CJ; Sengupta DJ; Unadkat JD
    Biochem J; 2004 May; 380(Pt 1):131-7. PubMed ID: 14759222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of equilibrative nucleoside transporters (hENT1 and hENT2) in nuclear envelopes of cultured human choriocarcinoma (BeWo) cells by functional reconstitution in proteoliposomes.
    Mani RS; Hammond JR; Marjan JM; Graham KA; Young JD; Baldwin SA; Cass CE
    J Biol Chem; 1998 Nov; 273(46):30818-25. PubMed ID: 9804860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues.
    Yao SY; Ng AM; Muzyka WR; Griffiths M; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 1997 Nov; 272(45):28423-30. PubMed ID: 9353301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine.
    SenGupta DJ; Lum PY; Lai Y; Shubochkina E; Bakken AH; Schneider G; Unadkat JD
    Biochemistry; 2002 Feb; 41(5):1512-9. PubMed ID: 11814344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole.
    Visser F; Vickers MF; Ng AM; Baldwin SA; Young JD; Cass CE
    J Biol Chem; 2002 Jan; 277(1):395-401. PubMed ID: 11689555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation.
    Yao SY; Ng AM; Vickers MF; Sundaram M; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 2002 Jul; 277(28):24938-48. PubMed ID: 12006583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2.
    Stolk M; Cooper E; Vilk G; Litchfield DW; Hammond JR
    Biochem J; 2005 Mar; 386(Pt 2):281-9. PubMed ID: 15500446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia.
    Aguayo C; Casado J; González M; Pearson JD; Martín RS; Casanello P; Pastor-Anglada M; Sobrevia L
    Placenta; 2005; 26(8-9):641-53. PubMed ID: 16085043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q).
    Vickers MF; Mani RS; Sundaram M; Hogue DL; Young JD; Baldwin SA; Cass CE
    Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):21-32. PubMed ID: 10085223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells.
    Boleti H; Coe IR; Baldwin SA; Young JD; Cass CE
    Neuropharmacology; 1997 Sep; 36(9):1167-79. PubMed ID: 9364472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residue 33 of human equilibrative nucleoside transporter 2 is a functionally important component of both the dipyridamole and nucleoside binding sites.
    Visser F; Zhang J; Raborn RT; Baldwin SA; Young JD; Cass CE
    Mol Pharmacol; 2005 Apr; 67(4):1291-8. PubMed ID: 15644498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter.
    Bone DB; Hammond JR
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3325-32. PubMed ID: 17921321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiae.
    Vickers MF; Kumar R; Visser F; Zhang J; Charania J; Raborn RT; Baldwin SA; Young JD; Cass CE
    Biochem Cell Biol; 2002; 80(5):639-44. PubMed ID: 12440703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residues Met89 and Ser160 in the human equilibrative nucleoside transporter 1 affect its affinity for adenosine, guanosine, S6-(4-nitrobenzyl)-mercaptopurine riboside, and dipyridamole.
    Endres CJ; Unadkat JD
    Mol Pharmacol; 2005 Mar; 67(3):837-44. PubMed ID: 15557207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system.
    Jennings LL; Hao C; Cabrita MA; Vickers MF; Baldwin SA; Young JD; Cass CE
    Neuropharmacology; 2001 Apr; 40(5):722-31. PubMed ID: 11311901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.